In the TEE (+) group, LAAT was observed in 26 patients (7.18%). None of the patients had a thromboembolic event within the first month of follow-up. In this observational study, we investigated ...

Low-molecular-weight heparins such as enoxaparin have shown benefit in MI and unstable angina and have been more effective in preventing venous thrombosis than unfractionated heparin. The latter is, ...

PRINCETON, N.J. & NEW YORK--Bristol-Myers Squibb Company and Pfizer Inc. today announced that the first patient has been enrolled into a Phase IV clinical trial called EMANATE (Eliquis evaluated in ...

Cardioversion is a procedure that returns an abnormal heart rhythm to normal. It's used when you have an arrhythmia, which means your heart is beating too fast or irregularly. Cardioversion can be ...

In this prospective observational study, consecutive patients (recruited between January 2002 and October 2004) with persistent AF who scheduled for elective external EC were screened. The patients ...

Bristol-Myers Squibb Company (BMS), a global biopharmaceutical company, and Pfizer Inc. announced that the first patient has been enrolled into a phase IV clinical trial called EMANATE (Eliquis ...

Q-I`ve been treated for an abnormal heartbeat for several months, without too much success. My new doctor advises that an electric shock might be used to correct the beat. It`s a frightening thought.

The ankle–brachial index (ABI) is the ratio of the systolic blood pressure (SBP) measured at the ankle to SBP measured at the brachial artery. 1, 2 The ABI is used for noninvasive diagnosis of ...

Stroke and major bleeding rates after cardioversion among patients from the RE-LY trial who were taking two doses of dabigatran were low and comparable with those who were treated with warfarin. In ...

Bayer and Janssen's novel oral anticoagulant (NOAC) Xarelto can be used in place of warfarin in atrial fibrillation patients undergoing cardioversion to restore normal heart rhythm, according to a new ...